Trial Profile
Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Levosalbutamol (Primary) ; Salbutamol
- Indications Asthma
- Focus Adverse reactions; Registrational
- Sponsors Sunovion Pharmaceuticals
- 30 Oct 2010 New trial record